BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 31439558)

  • 1. Isolated adrenocorticotropic hormone (ACTH) deficiency and Guillain-Barré syndrome occurring in a patient treated with nivolumab.
    Pierrard J; Petit B; Lejeune S; Seront E
    BMJ Case Rep; 2019 Aug; 12(8):. PubMed ID: 31439558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolated Adrenocorticotropic Hormone Deficiency in Melanoma Patients Treated with Nivolumab.
    Kitano S; Tatsuno K; Ishibe J; Shimauchi T; Fujiyama T; Ito T; Ogawa N; Tokura Y
    Acta Derm Venereol; 2018 Jul; 98(7):704-705. PubMed ID: 29405244
    [No Abstract]   [Full Text] [Related]  

  • 3. Isolated adrenocorticotropic hormone deficiency associated with nivolumab therapy.
    Narahira A; Yanagi T; Cho KY; Nakamura A; Miyoshi H; Hata H; Imafuku K; Kitamura S; Shimizu H
    J Dermatol; 2017 Apr; 44(4):e70. PubMed ID: 27608187
    [No Abstract]   [Full Text] [Related]  

  • 4. Isolated adrenocorticotropic hormone deficiency and thyroiditis associated with nivolumab therapy in a patient with advanced lung adenocarcinoma: a case report and review of the literature.
    Ohara N; Kobayashi M; Ohashi K; Ito R; Ikeda Y; Kawaguchi G; Yoneoka Y; Hasegawa G; Takada T
    J Med Case Rep; 2019 Mar; 13(1):88. PubMed ID: 30909965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Case Report: A Variety of Immune-Related Adverse Events Triggered by Immune Checkpoint Inhibitors in a Subject With Malignant Melanoma: Destructive Thyroiditis, Aseptic Meningitis and Isolated ACTH Deficiency.
    Katakura Y; Kimura T; Kusano T; Tatsumi F; Iwamoto Y; Sanada J; Fushimi Y; Shimoda M; Kohara K; Nakanishi S; Kaku K; Mune T; Kaneto H
    Front Endocrinol (Lausanne); 2021; 12():722586. PubMed ID: 34712202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late-onset isolated adrenocorticotropic hormone deficiency caused by nivolumab: a case report.
    Takeno A; Yamamoto M; Morita M; Tanaka S; Kanazawa I; Yamauchi M; Kaneko S; Sugimoto T
    BMC Endocr Disord; 2019 Feb; 19(1):25. PubMed ID: 30782163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolated adrenocorticotropic hormone deficiency possibly caused by nivolumab in a metastatic melanoma patient.
    Fujimura T; Kambayashi Y; Furudate S; Kakizaki A; Hidaka T; Haga T; Hashimoto A; Morimoto R; Aiba S
    J Dermatol; 2017 Mar; 44(3):e13-e14. PubMed ID: 27440178
    [No Abstract]   [Full Text] [Related]  

  • 8. Nivolumab-induced hypothyroidism followed by isolated ACTH deficiency.
    Martins Machado C; Almeida Santos L; Barroso A; Oliveira MJ
    BMJ Case Rep; 2019 Aug; 12(8):. PubMed ID: 31466960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyponatremia can be a powerful predictor of the development of isolated ACTH deficiency associated with nivolumab treatment [Letter to the Editor].
    Cho KY; Miyoshi H; Nakamura A; Kurita T; Atsumi T
    Endocr J; 2017 Feb; 64(2):235-236. PubMed ID: 28070057
    [No Abstract]   [Full Text] [Related]  

  • 10. Primary hypothyroidism and isolated ACTH deficiency induced by nivolumab therapy: Case report and review.
    Zeng MF; Chen LL; Ye HY; Gong W; Zhou LN; Li YM; Zhao XL
    Medicine (Baltimore); 2017 Nov; 96(44):e8426. PubMed ID: 29095280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolated ACTH deficiency probably induced by autoimmune-related mechanism evoked with nivolumab.
    Kitajima K; Ashida K; Wada N; Suetsugu R; Takeichi Y; Sakamoto S; Uchi H; Matsushima T; Shiratsuchi M; Ohnaka K; Furue M; Nomura M
    Jpn J Clin Oncol; 2017 May; 47(5):463-466. PubMed ID: 28334791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolated Adrenocorticotropic Hormone Deficiency Caused by Nivolumab in a Patient with Metastatic Lung Cancer.
    Takaya K; Sonoda M; Fuchigami A; Hiyoshi T
    Intern Med; 2017 Sep; 56(18):2463-2469. PubMed ID: 28824067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolated ACTH deficiency induced by cancer immunotherapy: a systematic review.
    Iglesias P; Sánchez JC; Díez JJ
    Pituitary; 2021 Aug; 24(4):630-643. PubMed ID: 33761049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nivolumab-Associated Guillain-Barre Syndrome in a Patient With Non-Small-Cell Lung Cancer.
    Thapa B; Khalid S; Vakili R; Ui J; Misbah S
    Am J Ther; 2018; 25(6):e761-e763. PubMed ID: 29889678
    [No Abstract]   [Full Text] [Related]  

  • 15. Isolated ACTH deficiency in a patient with empty sella as revealed by severe hyponatremia.
    Doroftei NA; de Rudder C; de Visscher N; Hanon F
    Acta Clin Belg; 2016 Dec; 71(6):451-454. PubMed ID: 27176077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fulminant type 1 diabetes associated with Isolated ACTH deficiency induced by anti-programmed cell death 1 antibody-insight into the pathogenesis of autoimmune endocrinopathy.
    Okahata S; Sakamoto K; Mitsumatsu T; Kondo Y; Noso S; Ikegami H; Shiba T
    Endocr J; 2019 Apr; 66(4):295-300. PubMed ID: 30814440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pituitary-adrenal dysfunction caused by nivolumab for head and neck cancer.
    Hihara K; Sato H; Okamoto I; Katsube Y; Maruyama R; Tomioka R; Tanaka H; Tsukahara K
    Auris Nasus Larynx; 2019 Dec; 46(6):896-901. PubMed ID: 31350019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Idiopathic and isolated adrenocorticotropic hormone deficiency presenting as continuous epigastric discomfort without symptoms of hypoglycemia: a case report.
    Okauchi S; Tatsumi F; Kan Y; Horiya M; Mizoguchi A; Fushimi Y; Sanada J; Nishioka M; Shimoda M; Kohara K; Nakanishi S; Kaku K; Mune T; Kaneto H
    J Med Case Rep; 2019 Apr; 13(1):113. PubMed ID: 31036085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolated adrenocorticotropic hormone deficiency associated with sintilimab therapy in a patient with advanced lung adenocarcinoma: a case report and literature review.
    Lin SH; Zhang A; Li LZ; Zhao LC; Wu LX; Fang CT
    BMC Endocr Disord; 2022 Sep; 22(1):239. PubMed ID: 36153581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoimmune polyendocrine syndrome type 3, characterized by autoimmune thyroid disease, type 1 diabetes mellitus, and isolated ACTH deficiency, developed during adjuvant nivolumab treatment.
    Takata M; Nomura M; Yamamura K; Muto M; Komori T; Otsuka A; Kabashima K
    Asia Pac J Clin Oncol; 2022 Aug; 18(4):481-482. PubMed ID: 33870636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.